# Chart source index

All checked October 14, 2026. Source IDs printed in the chart match the page and dataset.

- **S01**: [Ozempic injection prescribing information](https://www.novo-pi.com/ozempic.pdf). 12.3 Pharmacokinetics. Label revision: 05/2026 (cover).
- **S02**: [Rybelsus and Ozempic oral-tablet prescribing information](https://www.novo-pi.com/rybelsus.pdf). 12.3 Pharmacokinetics. Label revision: 1/2026 (cover).
- **S03**: [Mounjaro prescribing information](https://pi.lilly.com/us/mounjaro-uspi.pdf). 12.3 Pharmacokinetics. Label revision: 08/2026 (cover).
- **S04**: [Victoza prescribing information](https://www.novo-pi.com/victoza.pdf). 12.3 Pharmacokinetics. Label revision: 10/2025 (cover).
- **S05**: [Trulicity prescribing information](https://pi.lilly.com/us/trulicity-uspi.pdf). 12.3 Pharmacokinetics. Label revision: 03/2026 (cover).
- **S06**: [Byetta label](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=53d03c03-ebf7-418d-88a8-533eabd2ee4f). 12.3 Pharmacokinetics. Label revision September 2025; DailyMed effective date September 2, 2025.
- **S07**: [Bydureon BCise label](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d18cfc4-e0de-4814-a712-c1b7c504bff5). 12.3 Pharmacokinetics. Label revision: 5/2025; DailyMed update May 28, 2025.
- **S08**: [Adlyxin prescribing information](https://products.sanofi.us/adlyxin/adlyxin.pdf). 12.3 Pharmacokinetics. Label revision June 2022.
- **S09**: [Symlin label](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=4aea30ff-eb0d-45c1-b114-3127966328ff). 12.3 Pharmacokinetics. Label revision: 12/2019 (highlights).
- **S10**: [Forteo prescribing information](https://pi.lilly.com/us/forteo-pi.pdf). 12.3 Pharmacokinetics. Label revision: 08/2026 (cover).
- **S11**: [Tymlos label](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=712143d9-e21e-4013-bb3b-3426a21060a8). 12.3 Pharmacokinetics. Label revision: 8/2026 (highlights).
- **S12**: [Egrifta SV label](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d783378-b02d-4f19-99dd-0fc91a042224). 12.3 Pharmacokinetics. Highlights revised February 2024; DailyMed updated July 29, 2026.
- **S13**: [Egrifta WR label](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75). 12.3 Pharmacokinetics. Highlights revised March 2025; DailyMed updated July 29, 2026.
- **S14**: [Vyleesi prescribing information](https://vyleesi.com/docs/Vyleesi-Full-Prescribing-Information.pdf). 12.3 Pharmacokinetics. Label revision: 03/2024 (cover).
- **S15**: [Sandostatin immediate-release injection label](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=4e2c9856-1836-49f0-9472-4dbeeb408f39). 12.3 Pharmacokinetics. Highlights revised July 2024; DailyMed effective July 22, 2026; record-end revision July 2026.
- **S16**: [Sandostatin LAR Depot label](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=d0b7fe9e-7000-4b79-ba3b-291ce92c14f9). 12.3 Pharmacokinetics. Highlights revised July 2024; DailyMed effective December 22, 2025; record-end revision December 2025.
- **S17**: [Somatuline Depot label](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=6e4a41fd-a753-4362-87ee-8cc56ed3660d). 12.3 Pharmacokinetics. Highlights revised July 2024; DailyMed effective October 11, 2024; record-end revision October 2024.